Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands and New Zealand
收藏NBER2003-10-01 更新2025-01-04 收录
下载链接：
https://www.nber.org/papers/w10007
下载链接
链接失效反馈官方服务：
资源简介：
This paper describes three prototypical systems of therapeutic reference pricing (RP) for pharmaceuticals -- Germany, the Netherlands, and New Zealand -- and examines their effects on the availability of new drugs, reimbursement levels, manufacturer prices and out-of-pocket surcharges to patients.
提供机构：
美国国家经济研究局
创建时间：
2003-10-01
